These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3922532)

  • 21. Platelet-aggregating immune complexes and intraplatelet serotonin in idiopathic glomerulonephritis and systemic lupus.
    Kasai N; Parbtani A; Cameron JS; Yewdall V; Shepherd P; Verroust P
    Clin Exp Immunol; 1981 Jan; 43(1):64-72. PubMed ID: 7249395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet tocopherol levels in mucocutaneous lymph node syndrome (MCLS: Kawasaki disease).
    Yaoi K; Yamashiro K; Nakagawa S; Mino M
    J Nutr Sci Vitaminol (Tokyo); 1983 Jun; 29(3):261-70. PubMed ID: 6619990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient thrombocytopenia with large platelets in Kawasaki disease.
    Asano T; Sudoh M; Watanabe M; Fujino O
    Pediatr Hematol Oncol; 2007; 24(7):551-4. PubMed ID: 17786792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis.
    Niwa Y; Sohmiya K
    J Pediatr; 1984 Jan; 104(1):56-60. PubMed ID: 6690675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
    Liu R; Gao F; Huo J; Yi Q
    Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets in Kawasaki patients: two different populations with different mitochondrial functions.
    Pietraforte D; Gambardella L; Marchesi A; Tarissi de Jacobis I; Villani A; Del Principe D; Malorni W; Straface E
    Int J Cardiol; 2014 Mar; 172(2):526-8. PubMed ID: 24491862
    [No Abstract]   [Full Text] [Related]  

  • 27. Fatal Kawasaki disease with coronary arteritis and no coronary aneurysms.
    Burke AP; Virmani R; Perry LW; Li L; King TM; Smialek J
    Pediatrics; 1998 Jan; 101(1 Pt 1):108-12. PubMed ID: 9417162
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on the platelet mucocutaneous lymph node syndrome (MCLS)--platelet function--].
    Mukaiyama H
    Rinsho Ketsueki; 1982 Apr; 23(4):449-58. PubMed ID: 6215508
    [No Abstract]   [Full Text] [Related]  

  • 29. Kawasaki disease.
    Soman M; Faulkner S; Snively GG
    J Fam Pract; 1983 Apr; 16(4):723-6. PubMed ID: 6833960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum interleukin-6 in Kawasaki disease.
    Kim DS
    Yonsei Med J; 1992 Jun; 33(2):183-8. PubMed ID: 1413896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extreme thrombocytosis predicts Kawasaki disease in infants.
    Nigrovic LE; Nigrovic PA; Harper MB; Chiang VW
    Clin Pediatr (Phila); 2006 Jun; 45(5):446-52. PubMed ID: 16891278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome.
    Ueno K; Nomura Y; Hashiguchi T; Masuda K; Morita Y; Hazeki D; Eguchi T; Maruyama I; Kawano Y
    Br J Haematol; 2010 Jan; 148(2):285-92. PubMed ID: 19793253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOluble and insoluble immune complex-platelet interactions in rheumatoid inflammation.
    Yeatts RP; Turner R; Collins R; Kaufmann J; Mashburn H
    Ann Rheum Dis; 1978 Oct; 37(5):421-7. PubMed ID: 718274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.
    Cloutier N; Allaeys I; Marcoux G; Machlus KR; Mailhot B; Zufferey A; Levesque T; Becker Y; Tessandier N; Melki I; Zhi H; Poirier G; Rondina MT; Italiano JE; Flamand L; McKenzie SE; Cote F; Nieswandt B; Khan WI; Flick MJ; Newman PJ; Lacroix S; Fortin PR; Boilard E
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1550-E1559. PubMed ID: 29386381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating immune complexes and platelet IgG in various diseases.
    Puram V; Giuliani D; Morse BS
    Clin Exp Immunol; 1984 Dec; 58(3):672-6. PubMed ID: 6509798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [IgG subclasses in the serum and circulating immune complexes in patients with Kawasaki disease].
    Li CR
    Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):578-81, 40. PubMed ID: 2620267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravascular platelet activation in the hemolytic uremic syndrome.
    Walters MD; Levin M; Smith C; Nokes TJ; Hardisty RM; Dillon MJ; Barratt TM
    Kidney Int; 1988 Jan; 33(1):107-15. PubMed ID: 3280851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On morphogenesis of arteritis and aneurysm of the coronary artery in Kawasaki disease.
    Naoe S; Tanaka N; Masuda H; Atobe T
    Prog Clin Biol Res; 1987; 250():525. PubMed ID: 3423062
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recent research on platelet-leukocyte aggregates and their role in the pathogenesis of Kawasaki disease].
    Gao LC; Gong FQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun; 25(6):587-594. PubMed ID: 37382127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD84 is markedly up-regulated in Kawasaki disease arteriopathy.
    Reindel R; Bischof J; Kim KY; Orenstein JM; Soares MB; Baker SC; Shulman ST; Perlman EJ; Lingen MW; Pink AJ; Trevenen C; Rowley AH
    Clin Exp Immunol; 2014 Jul; 177(1):203-11. PubMed ID: 24635044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.